Boiron : Q2 2023 sales came in short of our estimate
>Q2 sales: Covid test volumes/prices down further - Q2 sales came in at € 107.6m, down 3.1%, -1.5%cc.Q2 2023 sales were down 3.1%, but adjusted for the decline in Covid test sales, the increase would have been 1.3%. In the six months to end June, sales were down 6.6%, impacted by the base effect from the high sales of Covid tests in France in H1 2022. Excluding Covid tests, sales were up by 6.2%.Covid test sales plummet, new products make inroads int...Boiron manufactures and markets homeopathic medicines. Homeopathic medicines are prepared from vegetable, animal, mineral, or chemical substances, which are diluted. Co. sells three types of products in 59 countries: Non-proprietary homeopathic medicines, OTC family medication specialties, and Other products. There are two large families of homeopathic medicines: Those associated with precise therapeutic indications and dosage, and those that do not mention a therapeutic indication or dosage. Co. supports homeopathy education and training organizations for healthcare professionals. Some of Co.'s brand names include Oscillococcinum®, Stodal®, S?datif PC®, and Coryzalia.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.